369. Assessing the predictive and prognostic value of the biomarker TP53 in patients with resectable colorectal liver metastases treated with and without neoadjuvant fluorouracil based chemotherapy: A p53 research group study

Authors :: Martina Mittlböck
Thomas Grünberger
N. Pilat
Daniela Kandioler
B. Perisanidis
Ferdinand Mühlbacher
Irene Kührer
F.L. Längle
Brigitte Wolf
Sonja Kappel
Source :: European Journal of Surgical Oncology (EJSO). 40:S142-S143
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.

Subjects :: Oncology
medicine.medical_specialty
Chemotherapy
Group study
business.industry
medicine.medical_treatment
General Medicine
Fluorouracil
Internal medicine
Medicine
Biomarker (medicine)
Surgery
In patient
business
medicine.drug

Tools